In previous work, we identified that Ewing sarcoma cell lines require active protein synthesis to maintain a stable level of the ribonucleotide reductase M2 (RRM2) protein, which is a potential therapeutic target in Ewing sarcoma tumors (12, 34, 39, 40). This evidence concerns the gene RRM2 and Ewing sarcoma.